^99mTc-Sucralfate Scintigraphy in Inflammatory Bowel Disease

Abstract

Technetium-99m-labeled albumin-sucralfate was orally administered to 11 patients (Crohn's disease, 8; ulcerative colitis, 3) and 3 healthy volunteers. Serial scintigraphy was performed, and scintigraphic interpretations were compared with radiographic and endoscopic findings in an open study. We were not able in any patient to relate the scintigraphic findings to the localizations of inflammatory bowel disease, nor could we distinguish the scans in the patients from the scans of the healthy volunteers. We conclude that ^99mTc-albumin-sucralfate scintigraphy is of no value in the detection of inflammatory bowel disease.

Key Words:

• Inflammatory bowel disease
• Scintigraphy
• Sucralfate
• technetium